Clinical trial
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet…
NCT00003851 · Columbia University, Other · Terminated
Key facts
| NCT number | NCT00003851 |
|---|---|
| Title | Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer |
| Official title | Evaluation of Intensive Pancreatic Proteolytic Enzyme Therapy With Ancillary Nutritional Support Versus Gemcitabine Chemotherapy in the Treatment of Inoperable Pancreatic Adenocarcinoma |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Malnutrition, Pancreatic Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | proteolytic enzymes, gemcitabine hydrochloride, Gonzalez regimen |
| Enrollment | 90 |
| Start date | Mar 1, 1999 |
| Primary completion | Jul 1, 2004 |
| Completion | Jul 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: